SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-233120
Filing Date
2020-08-27
Accepted
2020-08-27 16:05:46
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d911955d10q.htm 10-Q 851012
2 EX-31.1 d911955dex311.htm EX-31.1 11377
3 EX-31.2 d911955dex312.htm EX-31.2 11411
4 EX-32.1 d911955dex321.htm EX-32.1 6402
  Complete submission text file 0001193125-20-233120.txt   3851467

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rlay-20200630.xml EX-101.INS 811388
6 XBRL TAXONOMY EXTENSION SCHEMA rlay-20200630.xsd EX-101.SCH 32522
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rlay-20200630_cal.xml EX-101.CAL 27964
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rlay-20200630_def.xml EX-101.DEF 121131
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20200630_lab.xml EX-101.LAB 276596
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20200630_pre.xml EX-101.PRE 218932
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 201142848
SIC: 2836 Biological Products, (No Diagnostic Substances)